Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence, Efficacy and Durability Trial

Sponsor
NorthShore University HealthSystem (Other)
Overall Status
Recruiting
CT.gov ID
NCT04881721
Collaborator
(none)
15
1
16.2
0.9

Study Details

Study Description

Brief Summary

In this proposed study, the investigators aim to evaluate a modified suture urethropexy technique for the treatment of female stress urinary incontinence.

Participants will be followed with postoperative visits after 2 weeks, 2 months, and 12 months. Pelvic floor ultrasound imaging will be performed before surgery and after 2 months and 12 months, to evaluate urethral mobility.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Urethropexy

Detailed Description

This study is designed as a prospective observational study. The hypothesis is that suture urethropexy will improve stress urinary incontinence symptoms in participants with stress urinary incontinence and normal urethral closure pressure at 2 months and 12 months after surgery.

Specific Aims:

Aim 1: Investigate the efficacy of this mesh-free suture based surgical technique for improving SUI symptoms

Aim 2: Investigate the efficacy of this mesh-free suture based surgical technique on key urethral support defects observed with 3D ultrasound

Study Design

Study Type:
Observational
Anticipated Enrollment :
15 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence, Efficacy and Durability Trial
Actual Study Start Date :
Aug 25, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Outcome Measures

Primary Outcome Measures

  1. Stress urinary incontinence symptoms [2 weeks]

    Severity of stress urinary incontinence symptoms by questionnaire

  2. Stress urinary incontinence symptoms [3 months]

    Severity of stress urinary incontinence symptoms by questionnaire

  3. Stress urinary incontinence symptoms [12 months]

    Severity of stress urinary incontinence symptoms by questionnaire

  4. Voiding dysfunction [Within 1 year of surgery]

    Rate of urinary retention after surgery

Secondary Outcome Measures

  1. Distal Urethral Motion [2 months]

    Distal urethral swing angle during Valsalva measured via pelvic ultrasound

  2. Distal Urethral Motion [12 months]

    Distal urethral swing angle during Valsalva measured via pelvic ultrasound

  3. Proximal Urethral Motion [2 months]

    Proximal urethral swing angle during Valsalva measured via pelvic ultrasound

  4. Proximal Urethral Motion [12 months]

    Proximal urethral swing angle during Valsalva measured via pelvic ultrasound

  5. Post-operative complications [Within 1 year of surgery]

    Rate of post-operative complications

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years or older with stress dominant urinary incontinence

  • Stress urinary incontinence confirmed by testing (e.g. urodynamics)

  • Able to provide informed consent and attend post-operative visits

Exclusion Criteria:
  • Detrusor overactivity (> 40cm H2O)

  • Maximum Urethral Closure Pressure (< 40 cm H2O)

  • Post void residual > 150 mL

  • Prior surgery for stress urinary incontinence with retained material (e.g. bulking agent, sling)

Contacts and Locations

Locations

Site City State Country Postal Code
1 NorthShore University HealthSystem Skokie Illinois United States 60076

Sponsors and Collaborators

  • NorthShore University HealthSystem

Investigators

  • Principal Investigator: Ghazaleh Rostami Nia, MD, NorthShore University HealthSystem

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
NorthShore University HealthSystem
ClinicalTrials.gov Identifier:
NCT04881721
Other Study ID Numbers:
  • EH21-062
First Posted:
May 11, 2021
Last Update Posted:
Jan 24, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2022